Portfolio company
Acesion Pharma ApS
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Acesion Pharma
The company develops ion channel inhibitors to treat atrial fibrillation for patients with cardiac arrhythmia.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
Allosteros Therapeutics, Inc
The company develops small-molecule inhibitors of the protein kinase CaMKII to treat cardiovascular conditions including atrial fibrillation, ventricular arrhythmia and heart failure.
Brano Therapeutics
This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.
Arvada
This drug discovery and development company creates medicines for patients with abnormal heart rhythms.
AnaCardio
This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.
InCarda Therapeutics
This biopharmaceutical company develops inhaled therapies to treat patients with acute cardiovascular conditions such as paroxysmal atrial fibrillation.
Kardium
This company develops a mapping and pulsed field ablation system used by physicians to treat patients with atrial fibrillation.
